Related Experiment Video

Updated: Aug 5, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Clinical recommendations for the management of patients with type 1 diabetes in special situations

Estela Gil Poch1, Marta Ferrer Lozano2, Marta Murillo Vallés3

  • 1Servicio de Pediatría, Endocrinología Pediátrica, Hospital Materno Infantil, Complejo Hospitalario Universitario, Badajoz, Spain.

Anales De Pediatria
|July 31, 2026
PubMed

Insights

This consensus provides updated protocols for managing pediatric type 1 diabetes (T1D) in special situations. It aims to optimize glycemic control and prevent complications for improved patient outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Management

Background:

  • Type 1 diabetes (T1D) management in children and adolescents requires specialized protocols for unique circumstances.
  • Existing guidelines need regular updates to reflect current best practices in pediatric diabetes care.

Purpose of the Study:

  • To present consensus recommendations for managing pediatric T1D in special situations.
  • To provide evidence-based guidelines for optimizing glycemic control and preventing acute complications.

Main Methods:

  • Consensus development by the Spanish Society of Pediatric Endocrinology (SEEP) Diabetes Working Group.
  • Integration and adaptation of international guidelines from ISPAD 2022 and ADA 2026.
  • Detailed guidelines tailored to different treatment modalities for T1D.

Main Results:

  • The document offers specific, actionable recommendations for pediatric T1D management.
  • Guidelines address optimization of glycemic control across various treatment approaches.
  • Strategies for preventing and managing diabetes decompensation and acute complications are detailed.

Conclusions:

  • Coordinated management based on updated protocols is crucial for children and adolescents with T1D.
  • These recommendations facilitate improved care and outcomes in special situations.
  • The consensus serves as a vital resource for healthcare professionals managing pediatric T1D.

Keywords:
AIDCirugíaControl glucémicoDiabetes tipo 1Emergency departmentGlycemic controlMDIPediatricsPediatríaRadiaciónRadiationSurgeryType 1 diabetesUrgencias

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...